CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
0.15mg desogestrel /0.03mg ethinyl estradioldrug
Likely dose
0.15mg desogestrel /0.03mg ethinyl estradiolfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00204438
NCT00204438N/ACompleted
CompareCT.gov

Follicular Profiles After Administration of Oral Contraceptives at Different Times of the Follicular Phase of the Menstrual Cycle

University of Saskatchewan·interventional·Posted Sep 20, 2005·Updated Nov 28, 2016

In Brief

A clinical study evaluating 0.15mg desogestrel /0.03mg ethinyl estradiol for Contraception. Completed, across 1 site.

Detailed Summary

We hypothesize that administration of OCs at varying follicular diameters will provide an appropriate model for the study of follicular atresia in women. Clinically, we hypothesize that the administration on OCs at different stages of the follicular phase will result in markedly different patterns of follicular development and/or atresia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesCanada
CollaboratorsCanadian Institutes of Health Research (CIHR)

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 20, 2005
Enrollment StartFeb 1, 2002
Study CompletionDec 1, 2002
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

0.15mg desogestrel /0.03mg ethinyl estradioldrug